1. Home
  2. NSPR vs IAE Comparison

NSPR vs IAE Comparison

Compare NSPR & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.93

Market Cap

81.8M

Sector

Health Care

ML Signal

HOLD

Logo Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

IAE

Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

HOLD

Current Price

$7.33

Market Cap

80.3M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSPR
IAE
Founded
2005
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
81.8M
80.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NSPR
IAE
Price
$1.93
$7.33
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$4.50
N/A
AVG Volume (30 Days)
101.5K
46.3K
Earning Date
11-04-2025
01-01-0001
Dividend Yield
N/A
10.21%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,779,000.00
N/A
Revenue This Year
$22.76
N/A
Revenue Next Year
$75.45
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.04
N/A
52 Week Low
$1.59
$5.31
52 Week High
$3.80
$6.45

Technical Indicators

Market Signals
Indicator
NSPR
IAE
Relative Strength Index (RSI) 48.80 47.16
Support Level $1.74 $7.20
Resistance Level $2.00 $7.35
Average True Range (ATR) 0.12 0.11
MACD 0.01 0.01
Stochastic Oscillator 53.85 49.30

Price Performance

Historical Comparison
NSPR
IAE

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest

Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.

Share on Social Networks: